Atlassian (TEAM) Form 144: 490,560 Shares Proposed Sale ($84.7M)
Form 144 filed for Atlassian Corporation (TEAM) reporting a proposed sale of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form 144 filed for Atlassian Corporation (TEAM) reporting a proposed sale of common stock. The notice lists 490,560 shares to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $84,719,712 and 166,284,669 shares outstanding. The approximate date of sale is 09/09/2025 on NASDAQ. The shares were acquired as Founders Shares on 07/02/2010. The filing also discloses multiple prior 10b5-1 sales by the CANNON-BROOKES HEAD TRUST, each reporting 7,665 shares sold on numerous dates between 06/10/2025 and 09/08/2025 with daily gross proceeds shown. The filer certifies no undisclosed material information and, where applicable, reliance on a Rule 10b5-1 trading plan is indicated.
Positive
- Full disclosure of proposed sale size (490,560 shares) and aggregate market value ($84,719,712) in the Form 144
- Broker identified (Morgan Stanley Smith Barney LLC) and exchange specified (NASDAQ)
- Acquisition history provided (Founders Shares acquired 07/02/2010) and attestation regarding material nonpublic information
- Detailed listing of prior 10b5-1 sales by CANNON-BROOKES HEAD TRUST with dates and gross proceeds
Negative
- Large proposed disposal of 490,560 shares valued at $84,719,712 could be material to stakeholders
- Multiple recent sales under a 10b5-1 plan by CANNON-BROOKES HEAD TRUST are reported, indicating ongoing insider liquidity
Insights
TL;DR: An insider or affiliated account plans a sizable 144 sale worth $84.7M; prior systematic 10b5-1 sales are disclosed.
This Form 144 shows a proposed sale of 490,560 common shares valued at $84,719,712 to occur on 09/09/2025 via Morgan Stanley Smith Barney on NASDAQ. The shares originated as founders shares dated 07/02/2010. The filing separately details numerous executions under a 10b5-1 sales plan by CANNON-BROOKES HEAD TRUST, each for 7,665 shares across many dates from June through September 2025, with gross proceeds listed per trade. For market participants, the filing provides clear disclosure of the planned registered sale and the existence of continuing 10b5-1 program activity.
TL;DR: Governance disclosure appears complete: Form 144 lists acquisition history, planned sale, and 10b5-1 activity with a signer attestation.
The document includes the requisite information about the securities to be sold, the original acquisition (founders shares, 07/02/2010), and a representation that no material nonpublic information is known. It also documents recent sales executed under a Rule 10b5-1 plan by a named trust with dates and gross proceeds. From a governance and compliance perspective, the filing provides the standard attestations and broker details expected for a Rule 144 notice.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 for TEAM report?
Who is the broker handling the proposed sale in the TEAM Form 144?
Does the filing disclose prior insider sales?
Is there an attestation about material nonpublic information in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.